Literature DB >> 19086866

Molecular imaging with bioconjugates in mouse models of cancer.

Stephen Mather1.   

Abstract

The definition of molecular imaging provided by the Society of Nuclear Medicine is "the visualization, characterization and measurement of biological processes at the molecular and cellular levels in humans and other living systems". This review gives an overview of the technologies available for and the potential benefits from molecular imaging at the preclinical stage. It focuses on the use of imaging probes based on bioconjugates and for reasons of brevity confines itself to discussion of applications in the field of oncology, although molecular imaging can be equally useful in many fields including cardiovascular medicine, neurosciences, infection, and others.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19086866     DOI: 10.1021/bc800401x

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  8 in total

Review 1.  Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics.

Authors:  Anne Hellebust; Rebecca Richards-Kortum
Journal:  Nanomedicine (Lond)       Date:  2012-03       Impact factor: 5.307

2.  Cellular uptake and cytotoxicity of a near-IR fluorescent corrole-TiO2 nanoconjugate.

Authors:  Carl M Blumenfeld; Bryce F Sadtler; G Esteban Fernandez; Lily Dara; Cathie Nguyen; Felix Alonso-Valenteen; Lali Medina-Kauwe; Rex A Moats; Nathan S Lewis; Robert H Grubbs; Harry B Gray; Karn Sorasaenee
Journal:  J Inorg Biochem       Date:  2014-06-28       Impact factor: 4.155

3.  Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide.

Authors:  Joeri Kuil; Tessa Buckle; Hushan Yuan; Nynke S van den Berg; Shinya Oishi; Nobutaka Fujii; Lee Josephson; Fijs W B van Leeuwen
Journal:  Bioconjug Chem       Date:  2011-04-19       Impact factor: 4.774

4.  In vivo imaging using polymeric nanoparticles stained with near-infrared chemiluminescent and fluorescent squaraine catenane endoperoxide.

Authors:  Jung-Jae Lee; Alexander G White; Douglas R Rice; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2013-04-14       Impact factor: 6.222

5.  Magnetic nanoparticle-based hyperthermia for head & neck cancer in mouse models.

Authors:  Qun Zhao; Luning Wang; Rui Cheng; Leidong Mao; Robert D Arnold; Elizabeth W Howerth; Zhuo G Chen; Simon Platt
Journal:  Theranostics       Date:  2012-01-15       Impact factor: 11.556

6.  Radioiodination of BODIPY and its application to a nuclear and optical dual functional labeling agent for proteins and peptides.

Authors:  Masahiro Ono; Hiroyuki Watanabe; Yuki Ikehata; Ning Ding; Masashi Yoshimura; Kohei Sano; Hideo Saji
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

7.  Novel solid-phase strategy for the synthesis of ligand-targeted fluorescent-labelled chelating peptide conjugates as a theranostic tool for cancer.

Authors:  Sagnik Sengupta; Mena Asha Krishnan; Premansh Dudhe; Ramesh B Reddy; Bishnubasu Giri; Sudeshna Chattopadhyay; Venkatesh Chelvam
Journal:  Beilstein J Org Chem       Date:  2018-10-18       Impact factor: 2.883

8.  111In-labeled cystine-knot peptides based on the Agouti-related protein for targeting tumor angiogenesis.

Authors:  Lei Jiang; Zheng Miao; Richard H Kimura; Adam P Silverman; Gang Ren; Hongguang Liu; Hankui Lu; Jennifer R Cochran; Zhen Cheng
Journal:  J Biomed Biotechnol       Date:  2012-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.